SUMMARY
The fund has a target corpus of INR 1,600 Cr (around $185 Mn), has seen participation from family offices, UHNIs (ultra high net worth individuals), industry veterans and other institutions
The fund will invest in early to growth stage startups operating in the life sciences space which includes medical devices, digital health, consumer wellness, diagnostics and delivery
In the past two years, the Kotak Mahindra Group’s alternative assets management entity has invested a total of INR 4,000 Cr in the healthcare…
